Gendering Drugs: Feminist Studies of Pharmaceuticals
Editat de Ericka Johnsonen Limba Engleză Paperback – 13 iul 2018
This book, by bringing together critical pharmaceutical studies and feminist technoscience studies, explores the way drugs produce sexed and/or gendered identities for those who take – or resist – them, and how feminist technoscience studies can contribute a theoretical lens with which to observe sex and gender in the pharmaceuticalization processes. Topics explored in this diverse collection include the use of hormones to delay puberty onset for trans children; HPV vaccination against cervical cancer in Sweden, the UK, Austria and Colombia; Alzheimer’s discourses; and the medication of prostate issues. Ericka Johnson has brought together an innovative and timely collection that demonstrates gender as relevant in studies of pharmaceuticals, and provides multiple examples of methodological and theoretical tools to consider gender while studying drugs.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 631.45 lei 6-8 săpt. | |
Springer International Publishing – 13 iul 2018 | 631.45 lei 6-8 săpt. | |
Hardback (1) | 636.68 lei 6-8 săpt. | |
Springer International Publishing – 2 mar 2017 | 636.68 lei 6-8 săpt. |
Preț: 631.45 lei
Preț vechi: 742.88 lei
-15% Nou
Puncte Express: 947
Preț estimativ în valută:
120.90€ • 124.02$ • 101.79£
120.90€ • 124.02$ • 101.79£
Carte tipărită la comandă
Livrare economică 26 februarie-12 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319846644
ISBN-10: 3319846647
Pagini: 232
Ilustrații: XI, 232 p.
Dimensiuni: 148 x 210 mm
Greutate: 0.3 kg
Ediția:Softcover reprint of the original 1st ed. 2017
Editura: Springer International Publishing
Colecția Palgrave Macmillan
Locul publicării:Cham, Switzerland
ISBN-10: 3319846647
Pagini: 232
Ilustrații: XI, 232 p.
Dimensiuni: 148 x 210 mm
Greutate: 0.3 kg
Ediția:Softcover reprint of the original 1st ed. 2017
Editura: Springer International Publishing
Colecția Palgrave Macmillan
Locul publicării:Cham, Switzerland
Cuprins
1. Introduction.- Part I. Making Scientific and Medical Truths.- 2. Alzheimer’s in the Making.- 3. The Pharmaceuticalized Prostate.- 4. New Puberty; New Trans: Children, Pharmaceuticals and Politics.- Part II. Creating Subjectivities for “Patients” in Advertising.- 5. Prescribing Relational Subjectivities.- 6. You Will Protect Your Daughter, Right?.- Part III. Different HPV Vaccines.- 7. Evidence, Sex and State Paternalism.- 8. Young Women and the Pharmaceutical Burden of HPV Vaccinations.- 9. Two Shots for Children.- 10. Sexing Drugs, Refracting Discourses.
Notă biografică
Ericka Johnson is Senior Lecturer and Assistant Director of Technology and Social Change at Linköping University, Sweden. Her research interests include medical bodies and subjects as refracted by medical technologies.
Textul de pe ultima copertă
This book, by bringing together critical pharmaceutical studies and feminist technoscience studies, explores the way drugs produce sexed and/or gendered identities for those who take – or resist – them, and how feminist technoscience studies can contribute a theoretical lens with which to observe sex and gender in the pharmaceuticalization processes. Topics explored in this diverse collection include the use of hormones to delay puberty onset for trans children; HPV vaccination against cervical cancer in Sweden, the UK, Austria and Colombia; Alzheimer’s discourses; and the medication of prostate issues. Ericka Johnson has brought together an innovative and timely collection that demonstrates gender as relevant in studies of pharmaceuticals, and provides multiple examples of methodological and theoretical tools to consider gender while studying drugs.
Caracteristici
Combines interdisciplinary feminist science studies and science and technology studies Examines how gender can be seen in critical pharmaceutical studies Argues that the pharmaceutical studies field is 'gender-blind' and provides a set of tools to change this Acts as a valuable introductory book to the growing area of gender in pharmaceutical studies